We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$58.8B
AUM Growth
+$1.32B
(+2.3%)
Cap. Flow
-$493M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
17.5%
Holding
2,554
New
373
Increased
885
Reduced
846
Closed
330
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$367M |
| 2 |
TE Connectivity
TEL
|
+$209M |
| 3 |
VICI Properties
VICI
|
+$170M |
| 4 |
Amazon
AMZN
|
+$169M |
| 5 |
Eaton
ETN
|
+$168M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$403M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Accenture
ACN
|
+$119M |
| 4 |
Synchrony
SYF
|
+$110M |
| 5 |
Cardinal Health
CAH
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 10.02% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Relay Therapeutics
RLAY
$4.02B
| $736K | ﹤0.01% |
87,037
-100,784
| -54% | -$719K |
|
1677
Cytokinetics
CYTK
$11B
| $736K | ﹤0.01% |
+11,587
| New | +$721K |
|
1678
CALL
Alibaba
BABA
$269B
| $733K | ﹤0.01% |
+5,000
| New | +$814K |
|
|
1679
PUT
Alibaba
BABA
$269B
| $733K | ﹤0.01% |
+5,000
| New | +$814K |
|
1680
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $728K | ﹤0.01% |
+4,700
| New | +$704K |
|
1681
Ardelyx
ARDX
$1.24B
| $724K | ﹤0.01% |
124,211
-70,721
| -36% | -$394K |
|
1682
Enpro
NPO
$7.05B
| $722K | ﹤0.01% |
3,371
-2,486
| -42% | -$550K |
|
1683
Allogene Therapeutics
ALLO
$601M
| $721K | ﹤0.01% |
526,106
+244,054
| +87% | +$322K |
|
1684
CALL
Ross Stores
ROST
$76.6B
| $721K | ﹤0.01% |
+4,000
| New | +$667K |
|
|
1685
PUT
Ross Stores
ROST
$76.6B
| $721K | ﹤0.01% |
+4,000
| New | +$667K |
|
1686
SLM Corp
SLM
$4.57B
| $716K | ﹤0.01% |
26,473
-137,511
| -84% | -$3.77M |
|
1687
Univest Financial
UVSP
$1.23B
| $711K | ﹤0.01% |
+21,711
| New | +$680K |
|
1688
AMN Healthcare
AMN
$1.28B
| $710K | ﹤0.01% |
45,037
-307
| -0.7% | -$5.48K |
|
1689
Wintrust Financial
WTFC
$10.7B
| $702K | ﹤0.01% |
+5,022
| New | +$668K |
|
|
SLNO
1690
DELISTED
Soleno Therapeutics
SLNO
| $697K | ﹤0.01% |
15,047
+3,555
| +31% | +$195K |
|
1691
Transcat
TRNS
$793M
| $697K | ﹤0.01% |
+12,280
| New | +$765K |
|
1692
Contango Silver & Gold Inc
CTGO
$529M
| $696K | ﹤0.01% |
26,343
-3,859
| -13% | -$94.4K |
|
1693
Vermilion Energy
VET
$1.73B
| $694K | ﹤0.01% |
+83,187
| New | +$687K |
|
1694
Enanta Pharmaceuticals
ENTA
$372M
| $691K | ﹤0.01% |
43,847
+3,691
| +9% | +$46.9K |
|
1695
Enphase Energy
ENPH
$4.84B
| $691K | ﹤0.01% |
21,574
-207,185
| -91% | -$6.71M |
|
1696
AtriCure
ATRC
$1.77B
| $688K | ﹤0.01% |
17,401
-42,094
| -71% | -$1.54M |
|
1697
Parsons
PSN
$6.28B
| $686K | ﹤0.01% |
11,098
+3,132
| +39% | +$245K |
|
1698
Universal Display
OLED
$3.71B
| $685K | ﹤0.01% |
5,865
-7,885
| -57% | -$1.02M |
|
1699
Weis Markets
WMK
$1.82B
| $684K | ﹤0.01% |
+10,677
| New | +$713K |
|
1700
CALL
Analog Devices
ADI
$181B
| $678K | ﹤0.01% |
2,500
+200
| +9% | +$50.2K |
|
Similar funds
Man Group's Q4 2025 Portfolio in Review
As of Q4 2025, Man Group held 2,554 positions worth $58.8B, up 2.3% from $57.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group's Q4 2025 filing shows 373 new, 885 increased, 846 reduced and 330 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 540,865 shares worth $370M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Man Group's largest Q4 2025 buy was iShares Core S&P 500 ETF: 540,865 shares worth $370M.
- Man Group added most to TE Connectivity in Q4 2025, an estimated $209M increase.
- Man Group's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $403M.
- Man Group fully exited Kellanova in Q4 2025, selling an estimated $71.5M.
- Man Group's ten largest holdings make up 17% of its $58.8B portfolio in Q4 2025.
- Man Group opened 373 new positions and closed 330 in Q4 2025.
- Man Group's portfolio value rose 2.3% quarter-over-quarter to $58.8B.
Based on Man Group's 13F filing for Q4 2025, filed 17 Feb 2026.